Literature DB >> 32476886

Proceedings of the Americas Association of Sarcoidosis and Other Granulomatous Diseases (AASOG) 2017 annual meeting.

Richard C Bernstein1, Lisa A Maier2, Elliott Crouser3.   

Abstract

On April 7th and 8th, 2017; the Americas Association for Sarcoidosis and Other Granulomatous Diseases (AASOG) held its annual scientific conference titled "Combining Transformative Sarcoidosis Research and Outreach to Improve Health Disparities" at the Penn State Health, Hershey Campus Conference Center. Participants came from geographically diverse areas of the United States. The demographics of meeting speakers and attendees reflected the gender, racial and ethnic diversity of those who are engaged in the treatment of the disease. The AASOG meeting was held in conjunction with an FSR-sponsored sarcoidosis patient-physician conference, providing a unique forum to enhance communication between patients, providers and researchers. Cutting edge topics at the meeting included immunology, microbiome, genomics, and challenges in diagnosis and treatment of vulnerable populations. The meeting's clinical foci were neurosarcoidosis, fatigue, and small fiber neuropathy. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 91-94). Copyright:
© 2018.

Entities:  

Keywords:  macrophages; neurosarcoidosis; sarcoidosis; t-lymphocytes

Year:  2018        PMID: 32476886      PMCID: PMC7170063          DOI: 10.36141/svdld.v35i1.7325

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  11 in total

1.  Racial and ethnic disparities in health care: a position paper of the American College of Physicians.

Authors:  Rachel Groman; Jack Ginsburg
Journal:  Ann Intern Med       Date:  2004-08-03       Impact factor: 25.391

Review 2.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

Review 3.  Clinical phenotypes in sarcoidosis.

Authors:  Carlos A C Pereira; Marina C Dornfeld; Robert Baughman; Marc A Judson
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

4.  Racial difference in sarcoidosis mortality in the United States.

Authors:  Mehdi Mirsaeidi; Roberto F Machado; Dean Schraufnagel; Nadera J Sweiss; Robert P Baughman
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

5.  M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis.

Authors:  Stefan Prokop; Frank L Heppner; Hans H Goebel; Werner Stenzel
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  Fatigue is associated with quality of life in sarcoidosis patients.

Authors:  Helen J Michielsen; Marjolein Drent; Tatjana Peros-Golubicic; Jolanda De Vries
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

Review 7.  Sarcoidosis and small-fiber neuropathy.

Authors:  Jinny Tavee; Daniel Culver
Journal:  Curr Pain Headache Rep       Date:  2011-06

8.  Th2-M2 immunity in lesions of muscular sarcoidosis and macrophagic myofasciitis.

Authors:  Corinna Preusse; Hans-H Goebel; Debora Pehl; Jan L Rinnenthal; Rudolf A Kley; Yves Allenbach; Frank L Heppner; Matthias Vorgerd; François Jerôme Authier; Romain Gherardi; Werner Stenzel
Journal:  Neuropathol Appl Neurobiol       Date:  2015-05-19       Impact factor: 8.090

Review 9.  ARA 290 for treatment of small fiber neuropathy in sarcoidosis.

Authors:  Monique van Velzen; Lara Heij; Marieke Niesters; Anthony Cerami; Ann Dunne; Albert Dahan; Michael Brines
Journal:  Expert Opin Investig Drugs       Date:  2014-02-21       Impact factor: 6.206

10.  Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.

Authors:  Nicole A Braun; Lindsay J Celada; Jose D Herazo-Maya; Susamma Abraham; Guzel Shaginurova; Carla M Sevin; Jan Grutters; Daniel A Culver; Ryszard Dworski; James Sheller; Pierre P Massion; Vasiliy V Polosukhin; Joyce E Johnson; Naftali Kaminski; David S Wilkes; Kyra A Oswald-Richter; Wonder P Drake
Journal:  Am J Respir Crit Care Med       Date:  2014-09-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.